Malaria Chemoprevention in the Postdischarge Management of Severe Anemia | Zendy

Titus K. Kwambai | Zendy; Aggrey Dhabangi | Zendy; Richard Idro | Zendy; Robert O. Opoka | Zendy; Victoria Watson | Zendy; Simon Kariuki | Zendy; Nickline Kuya | Zendy; Eric D Onyango | Zendy; Kephas Otieno | Zendy; Aaron M. Samuels | Zendy; Meghna Desai | Zendy; Michaël Boele van Hensbroek | Zendy; Duolao Wang | Zendy; Chandy C. John | Zendy; Bjarne Robberstad | Zendy; Kamija S. Phiri | Zendy; Feiko O. ter Kuile | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Malaria Chemoprevention in the Postdischarge Management of Severe Anemia

Author(s) -

Titus K. Kwambai,

Aggrey Dhabangi,

Richard Idro,

Robert O. Opoka,

Victoria Watson,

Simon Kariuki,

Nickline Kuya,

Eric D Onyango,

Kephas Otieno,

Aaron M. Samuels,

Meghna Desai,

Michaël Boele van Hensbroek,

Duolao Wang,

Chandy C. John,

Bjarne Robberstad,

Kamija S. Phiri,

Feiko O. ter Kuile

Publication year - 2020

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa2002820

Subject(s) - medicine , hazard ratio , anemia , randomization , placebo , pediatrics , artesunate , malaria , artemether , confidence interval , randomized controlled trial , surgery , artemisinin , plasmodium falciparum , alternative medicine , pathology , immunology

Children who have been hospitalized with severe anemia in areas of Africa in which malaria is endemic have a high risk of readmission and death within 6 months after discharge. No prevention strategy specifically addresses this period.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research